Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria

References

• Shapley M, Mansell G, Jordan JL, et al. Positive predictive values of ≥5% in primary care for cancer: systematic review. Br J Gen Pract. 2010;60:e366–e377.
   PubMed Web of Science ®Google Scholar
• Sultana SR, Goodman CM, Byrne DJ, et al. Microscopic haematuria: urological investigation using a standard protocol. Br J Urol. 1996;78:691–696.
   PubMedGoogle Scholar
• Boman H, Hedelin H, Holmäng S. The results of routine evaluation of adult patients with haematuria analysed according to referral form information with 2-year follow-up. Scand J Urol Nephrol.2001;35:497–501.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hansen M, Berendse S, Hamilton W. The association between symptoms and bladder or renal tract cancer in primary care: a systematic review. Br J Gen Pract. 2015;65:e769–e775.
   PubMed Web of Science ®Google Scholar
• Hansen RP, Vedsted P, Sokolowski I, et al. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284–295.
   PubMed Web of Science ®Google Scholar
• Hollenbeck BK, Dunn RL, Ye Z, et al. Delays in diagnosis and bladder cancer mortality. Cancer 2010;116:5235–5242.
   PubMed Web of Science ®Google Scholar
• Bourgade V, Drouin SJ, Yates DR, et al. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival. World J Urol. 2014;32:475–479.
   PubMed Web of Science ®Google Scholar
• Hamilton W, Stapley S, Campbell C, et al. For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique. BMC Cancer. 2015;15:820–828.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–785.
   PubMed Web of Science ®Google Scholar
• Dobruch J, Daneshmand S, Fisch M, et al. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol. 2016;69:300–310.
   PubMed Web of Science ®Google Scholar
• Elmussareh M, Young M, Ordell Sundelin M, et al. Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark. Scand J Urol. 2017;51:282–289.
   PubMed Web of Science ®Google Scholar
• Bruyninckx R, Buntinx F, Aertgeerts B, et al. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract. 2003;53:31–35.
   PubMed Web of Science ®Google Scholar
• Lara J, Brunson A, Keegan TH, et al. Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry. J Urol. 2016;196:1378–1382.
   PubMed Web of Science ®Google Scholar
• Vasdev N, Thorpe AC. Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols? Urol Oncol. 2013;31:909–913.
   PubMed Web of Science ®Google Scholar
• Avidor Y, Nadu A, Matzkin H. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology 2000;55:22–24.
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, Naber KG, Weidner W. Asymptomatic bacteriuria in elderly patients: significance and implications for treatment. Drugs Aging. 2005;22:801–807.
   PubMed Web of Science ®Google Scholar
• Holmäng S. Mikroskopisk hematurin ingen varningsklocka för cancer. Läkartidningen 2016;113:1–3.
   Google Scholar
• Malmstrom PU. Time to abandon testing for microscopic haematuria in adults? BMJ. 2003;326:813–815.
   PubMed Web of Science ®Google Scholar
• Danish Urological Cancer Group. Danish haematuria guideline. 2015. Available from: http://ducg.dk/dablaca-blaerecancer/kliniske-retningslinjer/
   Google Scholar
• National Institute for Health and Care Excellence. NICE guidelines NG12. Suspected cancer: recognition and referral. 2015 [cited 2018 Apr 26]. Available from: www.nice.org.uk/guidance/ng12/evidence/full-guidance-74333341
   Google Scholar
• Smith AB, Carson CC. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review. Ther Clin Risk Manag. 2009;5:535–545.
   PubMedGoogle Scholar
• European Association of Urology. Guidelines. Non-muscle-invasive bladder cancer. 2017. [cited 2018 Apr 26]. Available from: http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/2017
   Google Scholar
• Baltacı S, Bozlu M, Yıldırım A, et al. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin. BJU Int. 2015;116:721–726.
   PubMed Web of Science ®Google Scholar
• Gore JL, Lai J, Setodji CM, et al. Urologic Diseases in America Project. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 2009;115:988–996.
   PubMed Web of Science ®Google Scholar
• Richards KA, Ruiz VL, Murphy DR, et al. Diagnostic evaluation of patients presenting with hematuria: an electronic health record-based study. Urol Oncol 2018;36:e19–88.
   Web of Science ®Google Scholar
• McCombie SP, Bangash HK, Kuan M, et al. Delays in the diagnosis and initial treatment of bladder cancer in Western Australia. BJU Int. 2017;120(Suppl 3):28–34.
   PubMed Web of Science ®Google Scholar
• Tomaszewski JJ, Handorf E, Corcoran AT, et al. Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer. J Urol. 2014;192:1349–1354.
   PubMed Web of Science ®Google Scholar
• Chappidi MR, Kates M, Tosoian JJ, et al. Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database. BJU Int. 2017;120:377–386.
   PubMed Web of Science ®Google Scholar
• Liedberg F, Gerdtham U, Gralén K, et al. Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study. Br J Cancer. 2016;115:770–775.
   PubMed Web of Science ®Google Scholar